Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2004-01-19 (22 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BEAUVAIS (60000), Oise
PHARMACIE DE MARISSEL : revenue, balance sheet and financial ratios
PHARMACIE DE MARISSEL is a French company
founded 22 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BEAUVAIS (60000),
this company of category PME
shows in 2022 a revenue of 1.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE MARISSEL (SIREN 451752711)
Indicator
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
1 323 070 €
1 219 884 €
N/C
N/C
1 357 931 €
1 350 785 €
Net income
13 943 €
9 179 €
-23 229 €
-40 245 €
9 276 €
17 935 €
21 562 €
EBITDA
N/C
23 969 €
-11 728 €
N/C
N/C
30 416 €
36 681 €
Net margin
N/C
0.7%
-1.9%
N/C
N/C
1.3%
1.6%
Revenue and income statement
In 2023, PHARMACIE DE MARISSEL generates positive net income of 14 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2023: 22 k€ -> 14 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
13 943 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 165%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 29%. The balance between equity and debt is satisfactory.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
165.17%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
28.827%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE MARISSEL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
Debt ratio
149.304
133.704
118.149
243.897
254.148
203.614
165.17
Financial autonomy
29.593
31.317
33.37
24.311
23.614
26.336
28.827
Repayment capacity
12.504
13.566
None
None
-25.83
38.147
None
Cash flow / Revenue
1.887%
1.619%
None%
None%
-1.503%
0.786%
None%
Sector positioning
Debt ratio
165.172023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average
In 2023, the debt ratio of PHARMACIE DE MARISSEL (165.17) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
28.83%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average
In 2023, the financial autonomy of PHARMACIE DE MARISSEL (28.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
38.15 years2022
2021
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Watch+50 pts over 2 years
In 2022, the repayment capacity of PHARMACIE DE MARISSEL (38.15) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 83.83. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
83.831
Liquidity indicators evolution PHARMACIE DE MARISSEL
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
Liquidity ratio
79.119
71.654
67.261
180.219
145.689
99.531
83.831
Interest coverage
26.319
30.586
None
None
-62.5
52.572
None
Sector positioning
Liquidity ratio
83.832023
2021
2022
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Watch-12 pts over 3 years
In 2023, the liquidity ratio of PHARMACIE DE MARISSEL (83.83) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
52.57x2022
2021
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Excellent+51 pts over 2 years
In 2022, the interest coverage of PHARMACIE DE MARISSEL (52.6x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 35 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 1034 days. Excellent situation: suppliers finance 999 days of the operating cycle (retail model).
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
35 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
1034 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE MARISSEL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
Operating WCR
127 636 €
136 024 €
0 €
0 €
65 337 €
115 372 €
0 €
Inventory turnover (days)
33
30
0
0
29
30
0
Customer payment term (days)
4
4
23
35
1
1
35
Supplier payment term (days)
55
60
1076
578
25
40
1034
Positioning of PHARMACIE DE MARISSEL in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE DE MARISSEL is estimated at
164 520 €
(range 100 052€ - 231 278€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
100k€164k€231k€
164 520 €Range: 100 052€ - 231 278€
NAF 5 année 2023
Valuation method used
Net Income Multiple
13 943 €
×
11.8x
=164 520 €
Range: 100 053€ - 231 278€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE MARISSEL with other companies in the same sector:
Frequently asked questions about PHARMACIE DE MARISSEL
What is the revenue of PHARMACIE DE MARISSEL ?
The revenue of PHARMACIE DE MARISSEL in 2022 is 1.3 M€.
Is PHARMACIE DE MARISSEL profitable?
Yes, PHARMACIE DE MARISSEL generated a net profit of 14 k€ in 2023.
Where is the headquarters of PHARMACIE DE MARISSEL ?
The headquarters of PHARMACIE DE MARISSEL is located in BEAUVAIS (60000), in the department Oise.
Where to find the tax return of PHARMACIE DE MARISSEL ?
The tax return of PHARMACIE DE MARISSEL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE MARISSEL operate?
PHARMACIE DE MARISSEL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart